Vorinostat, Bortezomib and Dexamethasone in Multiple Myeloma (MUKFour)
NCT01720875
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Vorinostat Velcade Dexamethasone
Sponsor
University of Leeds
Collaborators
[object Object]
[object Object]